Activation of Nuclear Factor-κB by Depolarization and Ca2+ Influx in MIN6 Insulinoma Cells

  1. Ernesto Bernal-Mizrachi,
  2. Wu Wen,
  3. Michael Shornick and
  4. M. Alan Permutt
  1. From the Washington University School of Medicine, Division of Endocrinology, Diabetes and Metabolism, St. Louis, Missouri

    Abstract

    The purpose of the current study was to determine whether nuclear factor-κB (NF-κB) activation is a component of the depolarization/Ca2+-dependent signaling in β-cells. MIN6 cells were transfected with a plasmid containing five tandem repeats of NF-κB binding sites linked to a luciferase reporter. The results of these experiments showed that KCl induced depolarization-activated NF-κB-dependent transcription (3.8-fold at 45 mmol/l, P < 0.01) in a concentration-dependent manner. Tumor necrosis factor-α (TNF-α), a known inducer of NF-κB signaling, activated this construct by 3.4-fold (P < 0.01). The response of NF-κB to depolarization was inhibited by the Ca2+-channel blocker verapamil and by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059 (70 and 62%, respectively). TNF-α, glucose, and KCl treatment resulted in inhibitory κBα degradation by Western blot analysis. TNF-α treatment and depolarization activation of NF-κB differed significantly in that TNF-α activation was not blocked by PD98059. Transfection with PKA, MEK, and MEK kinase induced NF-κB-dependent transcription by 20-, 90-, and 300-fold, respectively, suggesting that these pathways contribute to the activation in the depolarization response. These findings demonstrate that depolarization/Ca2+ influx, as well as TNF-α treatment, can activate NF-κB-dependent transcription in pancreatic β-cells, but by different signaling pathways. The current studies show that Ca2+ signals in pancreatic β-cells can activate transcription factors involved in the regulation of cell cycle and apoptosis. These findings now add NF-κB to the list of depolarization-induced transcription factors in pancreatic β-cells.

    Footnotes

    • Address correspondence and reprint requests to Ernesto Bernal-Mizrachi, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110. E-mail: ebernal{at}im.wustl.edu.

      Received for publication 19 March 2002 and accepted in revised form 1 June 2002.

      CaMK, CaM kinase; DMEM, Dulbecco’s modified Eagle’s medium; ERK, extracellular-regulated kinase; FBS, fetal bovine serum; IκB, inhibitory κB; KRBH, Krebs-Ringer bicarbonate HEPES; MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; MEKK, MEK kinase; NF-κB, nuclear factor-κB; PI, phosphatidylinositol; PKA, protein kinase A; PKC, protein kinase C; TNF-α, tumor necrosis factor-α.

      The symposium and the publication of this article have been made possible by an unrestricted educational grant from Servier, Paris.

    « Previous | Next Article »Table of Contents